🔎 Trials Near Me

Akèy › Leksemi mieloïd egi › Pennsylvania › Scranton

Etid klinik pou Leksemi mieloïd egi nan Scranton, PA

6 etid pou Leksemi mieloïd egi ap chèche patisipan nan sit nan ak bò kote Scranton (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi lwen
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi lwen
Laj 18 a 59 · Tout sèks · Mizajou Sep 28, 2026 · NCT05554393

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Ap rekriteFaz 2
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05564390

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06317649

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Ap rekriteFaz 2
  • Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi lwen
Laj 18 a 59 · Tout sèks · Mizajou Sep 22, 2026 · NCT05554406

Etid Leksemi mieloïd egi nan lòt vil

Lòt etid nan Scranton

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.